STAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial

Where should the safety bar be for studies investigating CAR-T therapies for autoimmune conditions?

STAT News·October 23, 2026·1 min read

or via:

Where should the safety bar be for studies investigating CAR-T therapies for autoimmune conditions?

This content is a summary of the original article published by STAT News. Visit the source for the full version.

Original Source

STAT News

Sponsored Listings